Lilly paused it coronavirus antibody drug trial

Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Hello,

Today in healthcare news: A setback to Eli Lilly’s antibody drug trial, why it’s too late to contact trace the Rose Garden ceremony, and an additional 75,000 people may have died because of COVID-19. 

Eli Lilly just paused its COVID-19 antibody drug trial over safety concerns

• Eli Lilly said Tuesday that it paused trials of its Covid-19 antibody treatment.
• The company said an independent board raised safety concerns and recommended the pause.
• President Donald Trump was treated with a similar antibody cocktail made by Regeneron while hospitalized earlier this month.

Read the full story from Graham Rapier here>>

It's too late to trace infections at the White House Rose Garden ceremony, experts say: 'I bet you we'll never find out'

• President Donald Trump and at least 34 White House staffers and contacts have been infected with the coronavirus following Judge Amy Coney Barrett's nomination ceremony at the White House Rose Garden on September 26.
• The White House accepted the CDC's offer to help with contact tracing, The Washington Post reported.
• Epidemiologists say those efforts may have come too late: People should be tested within two weeks of getting exposed.
• The outbreak has likely "spread beyond the White House at this point," one expert said.

Read the full story from Aria Bendix here>>

An additional 75,000 Americans may have died in the spring and summer because of COVID-19, a new study found

• Approximately 75,000 more Americans died from issues related to COVID-19 from the beginning of March to the beginning of August
• That's according to a peer-reviewed study published by researchers at Virginia Commonwealth University.
• The study found that the number of deaths in the US between March 1 and August 1 was 20% higher than is typical, but just 67% of the excess deaths had been officially attributed to the novel coronavirus. 

Read the full story from Connor Perrett here>>

More stories we're reading: 

• 2 drugmakers just hit setbacks in the coronavirus vaccine race, while 2 others forge ahead. Here's everything we know about the timeline for a COVID-19 vaccine and when you might be able to get a shot. (Business Insider)
• Teladoc is suing Amwell over patents (Stat News) 
• How a 38-year-old who taught himself health technology is shaping a key part of Amazon's plans to transform healthcare (Business Insider)
• A new rapid COVID-19 test that doesn't require additional equipment to process just got cleared in the US (Bloomberg)
• I volunteered to test one of the first experimental coronavirus vaccines. Here's what the experience was like and why it's given me hope for the world. (Business Insider)

Subscribe to this newsletter here. 

- Lydia